Scorpius Holdings, Inc. (SCPX)
OTCMKTS · Delayed Price · Currency is USD
0.0110
+0.0090 (450.00%)
Aug 8, 2025, 3:43 PM EDT
Chimerix Market Cap
Scorpius Holdings has a market cap or net worth of $672.57 thousand as of August 8, 2025. Its market cap has decreased by -73.83% in one year.
Market Cap
672.57K
Enterprise Value
23.44M
Revenue
6.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 24, 2013, Scorpius Holdings's market cap has decreased from 58.15M to 672.57K, a decrease of -98.84%. That is a compound annual growth rate of -30.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 672.57K | -58.14% |
| Dec 31, 2024 | 1.61M | -86.01% |
| Dec 29, 2023 | 11.48M | -44.42% |
| Dec 30, 2022 | 20.66M | -73.25% |
| Dec 31, 2021 | 77.23M | -36.90% |
| Dec 31, 2020 | 122.38M | 654.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 604.98M |
| Glass House Brands | 478.54M |
| Northwest Biotherapeutics | 365.69M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.51M |